P-glycoprotein and multidrug resistance
- 1 October 1996
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 6 (5) , 610-617
- https://doi.org/10.1016/s0959-437x(96)80091-8
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- What have we learnt thus far from mice with disrupted P-glycoprotein genes?European Journal Of Cancer, 1996
- Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cellsFEBS Letters, 1996
- Functional Reconstitution of P-glycoprotein Reveals an Apparent Near Stoichiometric Drug Transport to ATP HydrolysisJournal of Biological Chemistry, 1996
- The catalytic cycle of P‐glycoproteinFEBS Letters, 1995
- The role of the MDR protein in altered drug translocation across tumor cell membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Volume-sensitive Chloride Channel Activity Does Not Depend on Endogenous P-glycoproteinJournal of Biological Chemistry, 1995
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- Functional Dissection of P-glycoprotein Nucleotide-binding Domains in Chimeric and Mutant ProteinsPublished by Elsevier ,1995
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseasePublished by Elsevier ,1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993